Page last updated: 2024-11-04

sulfasalazine and Cheilitis

sulfasalazine has been researched along with Cheilitis in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Cheilitis: Inflammation of the lips. It is of various etiologies and degrees of pathology.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clayden, AM1
Bleys, CM1
Jones, SF1
Savage, NW1
Aldred, MJ1
Töndury, GD1

Other Studies

2 other studies available for sulfasalazine and Cheilitis

ArticleYear
Orofacial granulomatosis: a diagnostic problem for the unwary and a management dilemma. Case reports.
    Australian dental journal, 1997, Volume: 42, Issue:4

    Topics: Anti-Inflammatory Agents; Cheilitis; Child; Chronic Disease; Diagnosis, Differential; Face; Female;

1997
[Macrocheilia and morbus Crohn (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1977, Jun-28, Volume: 66, Issue:26

    Topics: Adult; Cheilitis; Crohn Disease; Female; Humans; Male; Middle Aged; Sulfasalazine; Triamcinolone

1977